VQPH Insider Trading Activity and SEC Form 4 Filings
VQPH insider trading summary
No open-market insider purchases or sales of VioQuest Pharmaceuticals, Inc. (VQPH) have been reported on SEC Form 4 in the past 12 months.
Latest VQPH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 14, 2008 | Michael D Becker | President and CEO | Buy | $4K (35,000 @ $0.10) |
| Jan 14, 2008 | Michael D Becker | President and CEO | Buy | $500 (5,000 @ $0.10) |
| Jan 14, 2008 | Stephen Rocamboli | Secretary | Buy | $2K (15,500 @ $0.11) |
| Jan 14, 2008 | Michael D Becker | President and CEO | Buy | $1K (10,000 @ $0.10) |
| Jan 14, 2008 | Brian Lenz | CFO and Treasurer | Buy | $1K (10,000 @ $0.12) |
| Feb 16, 2007 | Daniel E Greenleaf | President and CEO | Buy | $1K (2,500 @ $0.56) |
| Feb 16, 2007 | Daniel E Greenleaf | President and CEO | Buy | $9K (15,000 @ $0.57) |
| Feb 14, 2007 | Daniel E Greenleaf | President and CEO | Buy | $1K (2,500 @ $0.58) |
| Feb 7, 2007 | Edward C Bradley | Chief Sci. & Med. Officer | Buy | $5K (10,000 @ $0.51) |
| Apr 4, 2006 | Daniel E Greenleaf | President and CEO | Buy | $5K (5,000 @ $0.92) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.